Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Rocket Pharmaceuticals Inc shares valued at $34,400 were purchased by Bjork Elisabeth on Jan 02 ’26. At $3.44 per share, Bjork Elisabeth acquired 10,000 shares. The insider’s holdings grew to 50,000 shares worth approximately $0.19 million following the completion of this transaction.
Also, Schwartz Jonathan David sold 2,545 shares, netting a total of over 7,592 in proceeds. Following the sale of shares at $2.98 each, the insider now holds 299,064 shares.
Before that, Shah Gaurav had sold 6,276 shares from its account. In a trade valued at $18,721, the CEO traded Rocket Pharmaceuticals Inc shares for $2.98 each. Upon closing the transaction, the insider’s holdings decreased to 6,276 shares, worth approximately $2.89 million.
As published in a research note from JP Morgan on November 18, 2025, Rocket Pharmaceuticals Inc [RCKT] has been rated down from a Neutral to an Underweight. Analysts at BofA Securities upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in mid August. As of July 25, 2025, BofA Securities has decreased its “Buy” rating to a “Neutral” for RCKT. Earlier on May 30, 2025, Evercore ISI downgraded its rating. Their new recommendation was “an In-line” for RCKT stock which previously was a “an Outperform”.
Analyzing RCKT Stock Performance
On last trading session, Rocket Pharmaceuticals Inc [NASDAQ: RCKT] plunged -6.31% to $3.71. The stock’s lowest price that day was $3.685, but it reached a high of $3.955 in the same session. During the last five days, there has been a drop of approximately -4.38%. Over the course of the year, Rocket Pharmaceuticals Inc shares have dropped approximately -64.43%.
Support And Resistance Levels for Rocket Pharmaceuticals Inc (RCKT)
RSI (Relative Strength Index) is 54.44 on the 14-day chart, showing neutral technical sentiment.
Is Rocket Pharmaceuticals Inc subject to short interest?
Stocks of Rocket Pharmaceuticals Inc saw a sharp rise in short interest on 2025-12-31 jumping by 1.71 million shares to 12.74 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 11.03 million shares. A jump of 13.45% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 6.51 of the overall float, the days-to-cover ratio (short ratio) jumped to 6.51.
Which companies own the most shares of Rocket Pharmaceuticals Inc (RCKT)?
In terms of Rocket Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 6 in the next 12 months, up nearly 51.52% from the previous closing price of $3.96. Analysts anticipate Rocket Pharmaceuticals Inc stock to reach 7 by 2026, with the lowest price target being 5. In spite of this, 8 analysts ranked Rocket Pharmaceuticals Inc stock as Buy at the end of 2026. On May 28, 2025, Morgan Stanley assigned a price target of “an Equal-weight” to the stock and downgraded coverage with a $7.
